المؤلفون: Christina Pamporaki, Annika MA Berends, Angelos Filippatos, Tamara Prodanov, Leah Meuter, Aleksander Prejbisz, Felix Beuschlein, Martin Fassnacht, Henri Timmers, Svenja Noelting, Kaushik Ganesh Abhyankar, Georgiana Contsantinescu, Carola Kunath, Katharina Wang, Hanna Remde, Andrzej Januszewicz, Mercedes Robledo, Jacques Lenders, Michiel Kerstens, Karel Pacak, Graeme Eisenhofer

المصدر: Endocrine Abstracts.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5cdb09f886be8578e4fb9596571112ce
https://doi.org/10.1530/endoabs.81.oc13.6

المؤلفون: G Kats-Urgurlu, Thera P. Links, der Horst-Schrivers Ana van, M. N. Kerstens, Walter Noordzij, André Brouwers, Krijger Rr de, E Korpershoek, Ame Walenkamp, Etten B van, JW Bolt, MA Berends

المصدر: Endocrine Abstracts.

مصطلحات موضوعية: chemistry.chemical_compound, 18f fdopa, medicine.diagnostic_test, chemistry, Positron emission tomography, business.industry, medicine, Neuroendocrine tumors, medicine.disease, Nuclear medicine, business, Dihydroxyphenylalanine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::91544d04b25968b98b3e2d2a3336b7c8
https://doi.org/10.1530/endoabs.49.ep155

المؤلفون: Atalay S; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands., Berends SE; Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlands., Groenewoud HMM; Department for Health Evidence, Radboud Institute for Health Sciences, Radboudumc, Nijmegen, Netherlands., Mathot RAA; Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlands., Njoo DM; Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, Netherlands., Mommers JM; Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuis Groep Twente, Almelo, Netherlands., Koetsier MIA; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, Netherlands., Berends MA; Department of Dermatology, Slingelandziekenhuis, Doetinchem, Netherlands., de Vries A; Biologics Lab, Bioanalysis, Sanquin Diagnostic Services, Amsterdam, Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands., de Jong EMGJ; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands.; Radboud University, Nijmegen, Netherlands., van den Reek JMPA; Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands.

المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Aug; Vol. 33 (5), pp. 2680-2684. Date of Electronic Publication: 2022 Feb 23.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products*/therapeutic use , Psoriasis*/drug therapy, Adalimumab ; Biological Factors/therapeutic use ; Drug Tapering ; Etanercept ; Humans ; Treatment Outcome ; Ustekinumab

المؤلفون: Atalay S; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., van Vugt LJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Njoo MD; Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, the Netherlands., Mommers JM; Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, the Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuis Groep Twente, Almelo, the Netherlands., Koetsier MI; Department of Dermatology, Gelre ziekenhuizen, Apeldoorn, the Netherlands., Berends MA; Department of Dermatology, Slingelandziekenhuis, Doetinchem, the Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Groenewoud HMM; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Kievit W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.

المصدر: JAMA dermatology [JAMA Dermatol] 2020 Apr 01; Vol. 156 (4), pp. 393-400.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*administration & dosage , Dermatologic Agents/*administration & dosage , Etanercept/*administration & dosage , Psoriasis/*drug therapy , Ustekinumab/*administration & dosage, Adult ; Aged ; Biological Products/administration & dosage ; Drug Tapering ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Prospective Studies ; Psoriasis/pathology ; Quality of Life ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Zweegers J; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Roosenboom B; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PC; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Atalay S; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands., Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Bijen M; Ziekenhuisgroep Twente, Almelo/Hengelo, the Netherlands., Njoo MD; Ziekenhuisgroep Twente, Almelo/Hengelo, the Netherlands., Mommers JM; St. Anna Ziekenhuis, Geldrop, the Netherlands., van Lümig PP; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Driessen RJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Nijmegen, Nijmegen, the Netherlands.

المصدر: The British journal of dermatology [Br J Dermatol] 2017 Mar; Vol. 176 (3), pp. 786-793. Date of Electronic Publication: 2016 Oct 07.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Factors/*therapeutic use , Psoriasis/*drug therapy, Adalimumab/therapeutic use ; Etanercept/therapeutic use ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome ; Ustekinumab/therapeutic use

المؤلفون: Zweegers J; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PC; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands., Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Ossenkoppele PM; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Njoo MD; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Mommers JM; St Anna Ziekenhuis, Geldrop, the Netherlands., van Lümig PP; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Driessen RJ; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University, Nijmegen, the Netherlands.

المصدر: The British journal of dermatology [Br J Dermatol] 2016 Aug; Vol. 175 (2), pp. 340-7. Date of Electronic Publication: 2016 Jun 25.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*adverse effects , Anti-Inflammatory Agents/*adverse effects , Etanercept/*adverse effects , Psoriasis/*drug therapy , Ustekinumab/*adverse effects, Adalimumab/administration & dosage ; Anti-Inflammatory Agents/administration & dosage ; Biological Factors/adverse effects ; Body Mass Index ; Drug Administration Schedule ; Drug Substitution ; Etanercept/administration & dosage ; Female ; Humans ; Kaplan-Meier Estimate ; Long-Term Care ; Male ; Middle Aged ; Prospective Studies ; Registries ; Sex Characteristics ; Ustekinumab/administration & dosage

المؤلفون: van Lümig PP; Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. P.vanLumig@derma.umcn.nl, Driessen RJ, Berends MA, Boezeman JB, van de Kerkhof PC, de Jong EM

المصدر: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2012 Mar; Vol. 26 (3), pp. 283-91. Date of Electronic Publication: 2011 Mar 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*therapeutic use , Psoriasis/*drug therapy, Aged ; Biological Products/adverse effects ; Biomarkers/blood ; Comorbidity ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Poisson Distribution ; Prospective Studies ; Registries ; Treatment Outcome

المؤلفون: van Lingen RG; Department of Dermatology, Radboud University, Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. R.vanlingen@derma.umcn.nl, Körver JE, van de Kerkhof PC, Berends MA, van Rens DW, Langewouters AM, Boezeman JB, Seyger MM, de Jong EM

المصدر: The British journal of dermatology [Br J Dermatol] 2008 Jul; Vol. 159 (1), pp. 91-6. Date of Electronic Publication: 2008 Jul 01.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Immunoglobulin G/*therapeutic use , Immunosuppressive Agents/*therapeutic use , Psoriasis/*drug therapy , Receptors, Tumor Necrosis Factor/*therapeutic use , T-Lymphocyte Subsets/*drug effects, Antibodies, Monoclonal, Humanized ; Epidermis/drug effects ; Etanercept ; Female ; Flow Cytometry ; Humans ; Male ; Middle Aged ; Psoriasis/immunology ; Severity of Illness Index ; T-Lymphocyte Subsets/immunology ; Treatment Outcome

المؤلفون: Driessen RJ; Department of Dermatology, Radboud University Medical Centre, PO Box 9101, 6525 GL Nijmegen, The Netherlands. r.driessen@derma.umcn.nl, Berends MA, Boezeman JB, van de Kerkhof PC, de Jong EM

المصدر: The British journal of dermatology [Br J Dermatol] 2008 May; Vol. 158 (5), pp. 1098-106. Date of Electronic Publication: 2008 Mar 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0007-0963 (Print) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Immunoglobulin G/*therapeutic use , Immunosuppressive Agents/*therapeutic use , Psoriasis/*drug therapy , Receptors, Tumor Necrosis Factor/*therapeutic use, Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Cohort Studies ; Etanercept ; Female ; Humans ; Immunoglobulin G/adverse effects ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Prospective Studies

المؤلفون: van Lingen RG; Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. R.vanlingen@derma.umcn.nl, de Jong EM, Berends MA, Seyger MM, van Erp PE, van de Kerkhof PC

المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2008; Vol. 19 (5), pp. 284-7.

نوع المنشور: Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print Cited Medium: Print ISSN: 0954-6634 (Print) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Inflammatory Agents/*pharmacology , Antibodies, Monoclonal/*pharmacology , Dermatologic Agents/*pharmacology , Methotrexate/*pharmacology , Psoriasis/*metabolism , T-Lymphocytes/*drug effects, Adalimumab ; Adult ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Cell Compartmentation/drug effects ; Dermatologic Agents/therapeutic use ; Female ; Humans ; Lymphocyte Count ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Pilot Projects ; Psoriasis/drug therapy ; T-Lymphocytes/physiology